Other
Available for sale investments
Regeneron Pharmaceuticals Available for sale investments decreased by 1.2% to $15.53B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $13.30B to $15.53B. Over 5 years (FY 2020 to FY 2025), Available for sale investments shows an upward trend with a 33.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ4 2025
How to read this metric
An increase reflects a larger investment portfolio size, while fluctuations in value indicate changes in market interest rates and credit spreads.
Detailed definition
These are debt securities that are not classified as held-to-maturity or trading securities, representing investments th...
Peer comparison
Common in insurance portfolios to balance yield generation with liquidity requirements.
Metric ID:
other_available_for_sale_securities_debt_securitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.34B | $6.61B | $8.40B | $9.75B | $9.71B | $8.37B | $10.02B | $10.05B | $12.29B | $12.62B | $12.53B | $14.12B | $14.44B | $14.97B | $14.33B | $13.30B | $14.05B | $15.52B | $15.71B | $15.53B |
| QoQ Change | — | +52.5% | +26.9% | +16.1% | -0.4% | -13.8% | +19.7% | +0.3% | +22.3% | +2.7% | -0.7% | +12.6% | +2.3% | +3.7% | -4.3% | -7.2% | +5.6% | +10.5% | +1.2% | -1.2% |
| YoY Change | — | — | — | — | +123.9% | +26.5% | +19.3% | +3.1% | +26.5% | +50.8% | +25.1% | +40.4% | +17.5% | +18.6% | +14.3% | -5.8% | -2.7% | +3.7% | +9.7% | +16.7% |
Range$4.34B – $15.71B
CAGR+30.8%
Avg YoY Growth+24.2%
Median YoY Growth+18.0%
Available for sale investments at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's available for sale investments?
- Regeneron Pharmaceuticals (REGN) reported available for sale investments of $15.53B in Q1 2026.
- How has Regeneron Pharmaceuticals's available for sale investments changed year-over-year?
- Regeneron Pharmaceuticals's available for sale investments increased by 16.7% year-over-year, from $13.30B to $15.53B.
- What is the long-term trend for Regeneron Pharmaceuticals's available for sale investments?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's available for sale investments has grown at a 33.6% compound annual growth rate (CAGR), from $3.69B to $15.71B.
- What does available for sale investments mean?
- Debt investments held for an indefinite period that can be sold if needed.